Order Article Reprints

Berg AL, Rowson-Hodel A, Hu M, Keeling M, Wu H, VanderVorst K, Chen JJ, Hatakeyama J, Jilek J, Dreyer CA, et al. The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies. Cancers. 2022; 14(4):949. https://doi.org/10.3390/cancers14040949

Berg, Anastasia L., Ashley Rowson-Hodel, Michelle Hu, Michael Keeling, Hao Wu, Kacey VanderVorst, Jenny J. Chen, Jason Hatakeyama, Joseph Jilek, Courtney A. Dreyer, and et al. 2022. "The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies" Cancers 14, no. 4: 949. https://doi.org/10.3390/cancers14040949

Berg, A. L., Rowson-Hodel, A., Hu, M., Keeling, M., Wu, H., VanderVorst, K., Chen, J. J., Hatakeyama, J., Jilek, J., Dreyer, C. A., Wheeler, M. R., Yu, A.-M., Li, Y., & Carraway, K. L., III. (2022). The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies. Cancers, 14(4), 949. https://doi.org/10.3390/cancers14040949